Surrogate endpoints: Wishful thinking or reality?

被引：35

作者：

Baker, Stuart G. ^{[1
]}

机构：

[1] NCI, EPN 3131, Bethesda, MD 20892 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2006年 / 98卷 / 08期

关键词：

D O I：

10.1093/jnci/djj153

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：502 / 503

页数：2

共 11 条

[1] A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint [J].

Baker, SG .

BIOSTATISTICS, 2006, 7 (01) :58-70

[2] Criteria for the validation of surrogate endpoints in randomized experiments [J].

Buyse, M ;

Molenberghs, G .

BIOMETRICS, 1998, 54 (03) :1014-1029

[3]

Flandre P, 1999, STAT MED, V18, P107, DOI 10.1002/(SICI)1097-0258(19990115)18:1<107::AID-SIM965>3.3.CO

[4]

2-G

[5] Surrogate end points in clinical trials: Are we being misled? [J].

Fleming, TR ;

DeMets, DL .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613

[6] STATISTICAL VALIDATION OF INTERMEDIATE END-POINTS FOR CHRONIC DISEASES [J].

FREEDMAN, LS ;

GRAUBARD, BI ;

SCHATZKIN, A .

STATISTICS IN MEDICINE, 1992, 11 (02) :167-178

[7] LOGNORMAL DISTRIBUTIONS [J].

GADDUM, JH .

NATURE, 1945, 156 (3964) :463-466

[8] Accuracy optimisation for mould surface profile milling [J].

Lin, JC ;

Tai, CC .

INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY, 1999, 15 (01) :15-25

[9] Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16 [J].

Petrylak, DP ;

Ankerst, DP ;

Jiang, CS ;

Tangen, CM ;

Hussain, MHA ;

Lara, PN ;

Jones, JA ;

Taplin, ME ;

Burch, PA ;

Kohli, M ;

Benson, MC ;

Small, EJ ;

Raghavan, D ;

Crawford, ED .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (08) :516-521

[10] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA [J].

PRENTICE, RL .

STATISTICS IN MEDICINE, 1989, 8 (04) :431-440

← 1 2 →